Tender Offer - Concentra Biosciences, LLC

Form Type: SC TO-T

Filing Date: 2025-07-16

Corporate Action: Tender-offer

Type: New

Accession Number: 000114036125025957

Filing Summary: Concentra Biosciences, LLC, along with its subsidiaries, filed a Tender Offer Statement with the SEC for the third-party tender offer to acquire all issued and outstanding shares of IGM Biosciences, Inc. The offer price includes $1.247 in cash for each share, plus a non-transferable contractual contingent value right (CVR) for each share. This transaction is associated with a Merger Agreement dated July 1, 2025, which outlines the acquisition terms. As of June 27, 2025, IGM had a total of 60,189,151 shares outstanding. The filing indicates intentions regarding the future management of IGM and the execution of plans related to the tender offer and merger process.